SCHEMBL3306785

SCHEMBL3306785

Cc1cccc(Cc2cccc(C)c2C)c1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.47
ESR2 Q92731 1/20 0.47
TRPA1 O75762 1/20 0.46
ATM Q13315 1/20 0.46
GPR84 Q9NQS5 1/20 0.43
TP53 P04637 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2A6 P11509 1/20 0.41
TAAR1 Q96RJ0 1/20 0.41
HTR1B P28222 1/20 0.41
TSHR P16473 2/20 0.40
GABRA1 P14867 1/20 0.40
GABRB2 P47870 1/20 0.40
ACHE P22303 1/20 0.40
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6546855 0.93 TAAR1 (0.46) ESR1ESR2TRPA1ATMGPR84
SCHEMBL11202919 0.91 TAAR1 (0.45) ESR1ESR2TRPA1ATMGPR84
SCHEMBL6546715 0.89 GABRA1 (0.48) ESR1ESR2TRPA1ATMGPR84
SCHEMBL11208418 0.87 HTR2A (0.48) ESR1ESR2CYP1A2TSHRCYP3A4
SCHEMBL6546223 0.87 GABRA1 (0.46) ESR1ESR2TRPA1ATMGPR84
SCHEMBL1276090 0.85 CALM1 (0.48) ESR1ESR2CYP1A2TSHRCYP3A4
SCHEMBL19335777 0.85 ACHE (0.48) ESR1ESR2TP53MAPTTAAR1
SCHEMBL1834878 0.85 HSPA5 (0.64) ESR1ESR2TRPA1ATMTP53
SCHEMBL6546102 0.85 TAAR1 (0.41) ESR1ESR2TRPA1ATMGPR84
SCHEMBL11192895 0.85 MEN1 (0.48) TAAR1P2RX7SMN1; SMN2CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8492384-B2 Imidazolylalkylcarbonyl derivatives as calcium channel modulators and preparation method thereof KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2013-07-23 US claimed
US-20100292510-A1 PROCESS FOR PREPARING CYCLOALIPHATIC AMINES BASF SE (DE) 2010-11-18 US claimed
US-20090325979-A1 NOVEL IMIDAZOLYLALKYLCARBONYL DERIVATIVES AS CALCIUM CHANNEL MODULATORS AND PREPARATION METHOD THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2009-12-31 US claimed
EP-0502387-B1 Process for producing 3,3',4,4'-tetramethyldiphenylmethane MITSUBISHI GAS CHEMICAL CO (JP) 1995-04-26 EP claimed
US-5254768-A Catalytic isomerization MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1993-10-19 US claimed
EP-0502387-A1 Process for producing 3,3',4,4'-tetramethyldiphenylmethane MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1992-09-09 EP claimed
EP-0281784-A1 Perfluoro-1,1-di(orthoxylyl) alkyl compounds AIR PRODUCTS AND CHEMICALS, INC. (US) 1988-09-14 EP claimed
JP-4275241-A None JP disclosed
CN-118235091-A Transfer film, laminate having conductor pattern, method for producing laminate having conductor pattern, and method for producing transfer film 富士胶片株式会社 2024-06-21 CN disclosed
US-11724978-B2 Method for oxidizing a 1,1,-bis-(3,4-dimethylphenyl)-alkane to 3,3′,4,4′-benzophenone tetracarboxylic acid EVONIK FIBRES GMBH (AT) 2023-08-15 US disclosed
EP-3838883-B1 METHOD FOR OXIDIZING A 1,1-BIS-(3,4-DIMETHYLPHENYL)-ALKANE TO 3,3',4,4'-BENZOPHENONE TETRACARBOXYLIC ACID EVONIK FIBRES GMBH (AT) 2023-07-12 EP disclosed
CN-113929866-B Modified resin and resin composition 旭化成株式会社 2023-07-07 CN disclosed
CN-115121263-A Solid acid catalyst and preparation method and application thereof 华东理工大学 2022-09-30 CN disclosed
EP-0125342-A1 Process for preparation of aromatic polycarboxylic acids and intermediates therefor THE UPJOHN COMPANY (US) 1984-11-21 EP disclosed
US-4384871-A Dyestuff-containing microscopic capsule dispersion for record materials MITSUI TOATSU CHEMICALS, INC. (JP) 1983-05-24 US disclosed
EP-0007694-B1 PROCESS FOR PREPARING 3,4,3'4'-BENZOPHENONE-TETRACARBOXYLIC DIANHYDRIDE GULF RESEARCH & DEVELOPMENT COMPANY (US) 1983-04-06 EP disclosed
EP-0058430-A1 Dyestuff-containing microscopic capsule dispersion for record materials MITSUI TOATSU CHEMICALS, Inc. (JP) 1982-08-25 EP disclosed
WO-1980000149-A1 PROCESS FOR PREPARING 3,4,3',4'-BENZOPHENONETETRA-CARBOXYLIC DIANHYDRIDE GULF RESEARCH DEVELOPMENT CO (US) 1980-02-07 WO disclosed
EP-0007694-A1 Process for preparing 3,4,3'4'-benzophenone-tetracarboxylic dianhydride GULF RESEARCH & DEVELOPMENT COMPANY (US) 1980-02-06 EP disclosed
US-4173573-A Process for preparing 3,4,3,4-benzophenone-tetracarboxylic dianhydride GULF RESEARCH AND DEVELOPMENT COMPANY (US) 1979-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090325979-A1 NOVEL IMIDAZOLYLALKYLCARBONYL DERIVATIVES AS CALCIUM CHANNEL MODULATORS AND PREPARATION METHOD THEREOF CACNA1B, CACNA1C, ORAI1 ESR1 4432/4885ESR2 3398/4885TRPA1 66/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.